five

Observed versus scaled human plasma pharmacokinetics, recommended and given FIH dose levels for ST-246.

收藏
NIAID Data Ecosystem2026-03-07 收录
下载链接:
https://figshare.com/articles/dataset/_Observed_versus_scaled_human_plasma_pharmacokinetics_recommended_and_given_FIH_dose_levels_for_ST_246_/685261
下载链接
链接失效反馈
官方服务:
资源简介:
Extraction ratio = Cl/F/Cardiac Output. ¶ = First-in human (FIH) dose calculated by a slight modification (no safety factor applied) [26] of the pharmacologically guided approach provided in the United State Food and Drug Administration (USDFA) draft guidance [27] and expressed as follows: Dose (mg) = Animal AUC (h*µg/mL) × scaled human Cl/F (L/h). Where the applied AUC is the lowest observed systemic exposure value among the animal species utilized in this evaluation. a = Plasma clearance scaled by simple allometry. b = Plasma clearance scaled by MLP-corrected allometry. c = Apparent volume of distribution scaled by simple allometry. d = t1/2 calculated from the simple allometry human plasma clearance (Cl/F) and simple allometry human apparent volume of distribution (VD/F) using the equation: t1/2 = In2*(VD/F)scaled/(Cl/F)scaled. e = t1/2 calculated from the MLP-corrected allometry human plasma clearance (Cl/F) and simple allometry human apparent volume of distribution (VD/F) using the equation: t1/2 = In2*(VD/F)scaled/(Cl/F)scaled. f = Extraction ratio calculated from simple allometry human plasma clearance (Cl/F). g = Extraction ratio calculated from the MLP-corrected allometry human plasma clearance (Cl/F). h = Human pharmacokinetic estimates from a double-blind, randomized, placebo-controlled study following single daily oral administrations of ST-246 (in capsule form) at a dose of 400 mg for 14 days in non-fasted healthy adult human volunteers. i = Human pharmacokinetic estimates from a double-blind, randomized, placebo-controlled study following single daily oral administrations of ST-246 (in capsule form) at a dose of 600 mg for 14 days in non-fasted healthy adult human volunteers. j = Human pharmacokinetic estimates from a double-blind, randomized, placebo-controlled study following single daily oral administrations of ST-246 (in capsule form) at a dose of 800 mg for 21 days in non-fasted healthy adult human volunteers.
创建时间:
2013-04-18
二维码
社区交流群
二维码
科研交流群
商业服务